Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis

NCT00665639 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

454

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidiasis, Oral

Interventions

DRUG: micafungin
DRUG: caspofungin

Sponsor

Astellas Pharma Inc